Loading…

Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis

Functional biomarkers able to identify multiple sclerosis (MS) patients at high risk of fast disability progression are lacking. The aim of this study was to evaluate the ability of multimodal (upper and lower limbs motor, visual, lower limbs somatosensory) evoked potentials (EP) to monitor disease...

Full description

Saved in:
Bibliographic Details
Published in:BMC neurology 2016-06, Vol.16 (1), p.83-83, Article 83
Main Authors: Giffroy, Xavier, Maes, Nathalie, Albert, Adelin, Maquet, Pierre, Crielaard, Jean-Michel, Dive, Dominique
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c538t-3342a698f66f5e582b42aa8294fde9dc8ba2d83ac89dbecd3b7e31b3ba8175093
cites cdi_FETCH-LOGICAL-c538t-3342a698f66f5e582b42aa8294fde9dc8ba2d83ac89dbecd3b7e31b3ba8175093
container_end_page 83
container_issue 1
container_start_page 83
container_title BMC neurology
container_volume 16
creator Giffroy, Xavier
Maes, Nathalie
Albert, Adelin
Maquet, Pierre
Crielaard, Jean-Michel
Dive, Dominique
description Functional biomarkers able to identify multiple sclerosis (MS) patients at high risk of fast disability progression are lacking. The aim of this study was to evaluate the ability of multimodal (upper and lower limbs motor, visual, lower limbs somatosensory) evoked potentials (EP) to monitor disease course and identify patients exposed to unfavourable evolution. One hundred MS patients were assessed with visual, somatosensory and motor EP and rated on the Expanded Disability Status Scale (EDSS) at baseline (T0) and about 6 years later (T1). The Spearman correlation (rS) was used to evaluate the relationship between conventional EP scores and clinical findings. Multiple (logistic) regression analysis estimated the predictive value of baseline electrophysiological data for three clinical outcomes: EDSS, annual EDSS progression, and the risk of EDSS worsening. In contrast to longitudinal correlations, cross-sectional correlations between the different EP scores and EDSS were all significant (0.33 ≤ rS < 0.67, p < 0.001). Baseline global EP score and EDSS were highly significant predictors (p < 0.0001) of EDSS progression 6 years later. The baseline global EP score was found to be an independent predictor of the EDSS annual progression rate (p < 0.001), and of the risk of disability progression over time (p < 0.005). Based on a ROC curve determination, we defined a Global EP Score cut off point (17/30) to identify patients at high risk of disability progression illustrated by a positive predictive value of 70%. This study provides a proof of the concept that electrophysiology could be added to MRI and used as another complementary prognostic tool in MS patients.
doi_str_mv 10.1186/s12883-016-0608-1
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4888661</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A468861853</galeid><sourcerecordid>A468861853</sourcerecordid><originalsourceid>FETCH-LOGICAL-c538t-3342a698f66f5e582b42aa8294fde9dc8ba2d83ac89dbecd3b7e31b3ba8175093</originalsourceid><addsrcrecordid>eNptUstu1TAQjRCIlsIHsEGR2LBJ8SOxnQ1SVfGSitjAlpHjjIOLY9_ayZX69zi9pbQIeTH2zDnH4_GpqpeUnFKqxNtMmVK8IVQ0RBDV0EfVMW0lbRiX8vG9_VH1LOdLQqhULX1aHTHJ2o4xelz9-LL6xc1x1L7GffyFY72LC4bFaZ9rG1Nt12AWF0MBXK26FKwzekvUOhRwilOI2eXahXretHYe62w8pi37vHpiixC-uI0n1fcP77-df2ouvn78fH520ZiOq6XhvGVa9MoKYTvsFBvKWSvWt3bEfjRq0GxUXBvVjwOakQ8SOR34oBWVHen5SfXuoLtbhxlHUx6QtIddcrNO1xC1g4eV4H7CFPfQKqWEoEWAHwS8wwkhpsHBnt0Qb_arn0AbGBAYEwpor0oorDe316Z4tWJeYHbZoPc6YFwzUNnzTohe8gJ9_Q_0Mq6pTLWgFCGSqk6Sv6hJewQXbCzdmk0UzlpRWi2wTev0P6iyRpydiQGtK_kHBHogmPIrOaG9mwwlsFkJDlaCYiXYrATbRF7dH-kd4493-G_0sMVz</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1800718570</pqid></control><display><type>article</type><title>Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Giffroy, Xavier ; Maes, Nathalie ; Albert, Adelin ; Maquet, Pierre ; Crielaard, Jean-Michel ; Dive, Dominique</creator><creatorcontrib>Giffroy, Xavier ; Maes, Nathalie ; Albert, Adelin ; Maquet, Pierre ; Crielaard, Jean-Michel ; Dive, Dominique</creatorcontrib><description>Functional biomarkers able to identify multiple sclerosis (MS) patients at high risk of fast disability progression are lacking. The aim of this study was to evaluate the ability of multimodal (upper and lower limbs motor, visual, lower limbs somatosensory) evoked potentials (EP) to monitor disease course and identify patients exposed to unfavourable evolution. One hundred MS patients were assessed with visual, somatosensory and motor EP and rated on the Expanded Disability Status Scale (EDSS) at baseline (T0) and about 6 years later (T1). The Spearman correlation (rS) was used to evaluate the relationship between conventional EP scores and clinical findings. Multiple (logistic) regression analysis estimated the predictive value of baseline electrophysiological data for three clinical outcomes: EDSS, annual EDSS progression, and the risk of EDSS worsening. In contrast to longitudinal correlations, cross-sectional correlations between the different EP scores and EDSS were all significant (0.33 ≤ rS &lt; 0.67, p &lt; 0.001). Baseline global EP score and EDSS were highly significant predictors (p &lt; 0.0001) of EDSS progression 6 years later. The baseline global EP score was found to be an independent predictor of the EDSS annual progression rate (p &lt; 0.001), and of the risk of disability progression over time (p &lt; 0.005). Based on a ROC curve determination, we defined a Global EP Score cut off point (17/30) to identify patients at high risk of disability progression illustrated by a positive predictive value of 70%. This study provides a proof of the concept that electrophysiology could be added to MRI and used as another complementary prognostic tool in MS patients.</description><identifier>ISSN: 1471-2377</identifier><identifier>EISSN: 1471-2377</identifier><identifier>DOI: 10.1186/s12883-016-0608-1</identifier><identifier>PMID: 27245221</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Adult ; Biological activity ; Biomarkers - metabolism ; Confidence intervals ; Cross-Sectional Studies ; Data analysis ; Development and progression ; Disability ; Disabled Persons ; Disease Progression ; Electrodes ; Evoked potentials ; Evoked Potentials, Motor - physiology ; Evoked Potentials, Somatosensory - physiology ; Female ; Funding ; Human health sciences ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Multimodal Imaging - methods ; Multiple sclerosis ; Multiple Sclerosis - physiopathology ; Neurologie ; Neurology ; NMR ; Nuclear magnetic resonance ; Prognosis ; Retrospective Studies ; ROC Curve ; Sciences de la santé humaine ; Variance analysis</subject><ispartof>BMC neurology, 2016-06, Vol.16 (1), p.83-83, Article 83</ispartof><rights>COPYRIGHT 2016 BioMed Central Ltd.</rights><rights>Copyright BioMed Central 2016</rights><rights>The Author(s). 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c538t-3342a698f66f5e582b42aa8294fde9dc8ba2d83ac89dbecd3b7e31b3ba8175093</citedby><cites>FETCH-LOGICAL-c538t-3342a698f66f5e582b42aa8294fde9dc8ba2d83ac89dbecd3b7e31b3ba8175093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888661/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1800718570?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27245221$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Giffroy, Xavier</creatorcontrib><creatorcontrib>Maes, Nathalie</creatorcontrib><creatorcontrib>Albert, Adelin</creatorcontrib><creatorcontrib>Maquet, Pierre</creatorcontrib><creatorcontrib>Crielaard, Jean-Michel</creatorcontrib><creatorcontrib>Dive, Dominique</creatorcontrib><title>Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis</title><title>BMC neurology</title><addtitle>BMC Neurol</addtitle><description>Functional biomarkers able to identify multiple sclerosis (MS) patients at high risk of fast disability progression are lacking. The aim of this study was to evaluate the ability of multimodal (upper and lower limbs motor, visual, lower limbs somatosensory) evoked potentials (EP) to monitor disease course and identify patients exposed to unfavourable evolution. One hundred MS patients were assessed with visual, somatosensory and motor EP and rated on the Expanded Disability Status Scale (EDSS) at baseline (T0) and about 6 years later (T1). The Spearman correlation (rS) was used to evaluate the relationship between conventional EP scores and clinical findings. Multiple (logistic) regression analysis estimated the predictive value of baseline electrophysiological data for three clinical outcomes: EDSS, annual EDSS progression, and the risk of EDSS worsening. In contrast to longitudinal correlations, cross-sectional correlations between the different EP scores and EDSS were all significant (0.33 ≤ rS &lt; 0.67, p &lt; 0.001). Baseline global EP score and EDSS were highly significant predictors (p &lt; 0.0001) of EDSS progression 6 years later. The baseline global EP score was found to be an independent predictor of the EDSS annual progression rate (p &lt; 0.001), and of the risk of disability progression over time (p &lt; 0.005). Based on a ROC curve determination, we defined a Global EP Score cut off point (17/30) to identify patients at high risk of disability progression illustrated by a positive predictive value of 70%. This study provides a proof of the concept that electrophysiology could be added to MRI and used as another complementary prognostic tool in MS patients.</description><subject>Adult</subject><subject>Biological activity</subject><subject>Biomarkers - metabolism</subject><subject>Confidence intervals</subject><subject>Cross-Sectional Studies</subject><subject>Data analysis</subject><subject>Development and progression</subject><subject>Disability</subject><subject>Disabled Persons</subject><subject>Disease Progression</subject><subject>Electrodes</subject><subject>Evoked potentials</subject><subject>Evoked Potentials, Motor - physiology</subject><subject>Evoked Potentials, Somatosensory - physiology</subject><subject>Female</subject><subject>Funding</subject><subject>Human health sciences</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multimodal Imaging - methods</subject><subject>Multiple sclerosis</subject><subject>Multiple Sclerosis - physiopathology</subject><subject>Neurologie</subject><subject>Neurology</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>ROC Curve</subject><subject>Sciences de la santé humaine</subject><subject>Variance analysis</subject><issn>1471-2377</issn><issn>1471-2377</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptUstu1TAQjRCIlsIHsEGR2LBJ8SOxnQ1SVfGSitjAlpHjjIOLY9_ayZX69zi9pbQIeTH2zDnH4_GpqpeUnFKqxNtMmVK8IVQ0RBDV0EfVMW0lbRiX8vG9_VH1LOdLQqhULX1aHTHJ2o4xelz9-LL6xc1x1L7GffyFY72LC4bFaZ9rG1Nt12AWF0MBXK26FKwzekvUOhRwilOI2eXahXretHYe62w8pi37vHpiixC-uI0n1fcP77-df2ouvn78fH520ZiOq6XhvGVa9MoKYTvsFBvKWSvWt3bEfjRq0GxUXBvVjwOakQ8SOR34oBWVHen5SfXuoLtbhxlHUx6QtIddcrNO1xC1g4eV4H7CFPfQKqWEoEWAHwS8wwkhpsHBnt0Qb_arn0AbGBAYEwpor0oorDe316Z4tWJeYHbZoPc6YFwzUNnzTohe8gJ9_Q_0Mq6pTLWgFCGSqk6Sv6hJewQXbCzdmk0UzlpRWi2wTev0P6iyRpydiQGtK_kHBHogmPIrOaG9mwwlsFkJDlaCYiXYrATbRF7dH-kd4493-G_0sMVz</recordid><startdate>20160601</startdate><enddate>20160601</enddate><creator>Giffroy, Xavier</creator><creator>Maes, Nathalie</creator><creator>Albert, Adelin</creator><creator>Maquet, Pierre</creator><creator>Crielaard, Jean-Michel</creator><creator>Dive, Dominique</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>Q33</scope><scope>5PM</scope></search><sort><creationdate>20160601</creationdate><title>Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis</title><author>Giffroy, Xavier ; Maes, Nathalie ; Albert, Adelin ; Maquet, Pierre ; Crielaard, Jean-Michel ; Dive, Dominique</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c538t-3342a698f66f5e582b42aa8294fde9dc8ba2d83ac89dbecd3b7e31b3ba8175093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Biological activity</topic><topic>Biomarkers - metabolism</topic><topic>Confidence intervals</topic><topic>Cross-Sectional Studies</topic><topic>Data analysis</topic><topic>Development and progression</topic><topic>Disability</topic><topic>Disabled Persons</topic><topic>Disease Progression</topic><topic>Electrodes</topic><topic>Evoked potentials</topic><topic>Evoked Potentials, Motor - physiology</topic><topic>Evoked Potentials, Somatosensory - physiology</topic><topic>Female</topic><topic>Funding</topic><topic>Human health sciences</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multimodal Imaging - methods</topic><topic>Multiple sclerosis</topic><topic>Multiple Sclerosis - physiopathology</topic><topic>Neurologie</topic><topic>Neurology</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>ROC Curve</topic><topic>Sciences de la santé humaine</topic><topic>Variance analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Giffroy, Xavier</creatorcontrib><creatorcontrib>Maes, Nathalie</creatorcontrib><creatorcontrib>Albert, Adelin</creatorcontrib><creatorcontrib>Maquet, Pierre</creatorcontrib><creatorcontrib>Crielaard, Jean-Michel</creatorcontrib><creatorcontrib>Dive, Dominique</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Université de Liège - Open Repository and Bibliography (ORBI)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMC neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Giffroy, Xavier</au><au>Maes, Nathalie</au><au>Albert, Adelin</au><au>Maquet, Pierre</au><au>Crielaard, Jean-Michel</au><au>Dive, Dominique</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis</atitle><jtitle>BMC neurology</jtitle><addtitle>BMC Neurol</addtitle><date>2016-06-01</date><risdate>2016</risdate><volume>16</volume><issue>1</issue><spage>83</spage><epage>83</epage><pages>83-83</pages><artnum>83</artnum><issn>1471-2377</issn><eissn>1471-2377</eissn><abstract>Functional biomarkers able to identify multiple sclerosis (MS) patients at high risk of fast disability progression are lacking. The aim of this study was to evaluate the ability of multimodal (upper and lower limbs motor, visual, lower limbs somatosensory) evoked potentials (EP) to monitor disease course and identify patients exposed to unfavourable evolution. One hundred MS patients were assessed with visual, somatosensory and motor EP and rated on the Expanded Disability Status Scale (EDSS) at baseline (T0) and about 6 years later (T1). The Spearman correlation (rS) was used to evaluate the relationship between conventional EP scores and clinical findings. Multiple (logistic) regression analysis estimated the predictive value of baseline electrophysiological data for three clinical outcomes: EDSS, annual EDSS progression, and the risk of EDSS worsening. In contrast to longitudinal correlations, cross-sectional correlations between the different EP scores and EDSS were all significant (0.33 ≤ rS &lt; 0.67, p &lt; 0.001). Baseline global EP score and EDSS were highly significant predictors (p &lt; 0.0001) of EDSS progression 6 years later. The baseline global EP score was found to be an independent predictor of the EDSS annual progression rate (p &lt; 0.001), and of the risk of disability progression over time (p &lt; 0.005). Based on a ROC curve determination, we defined a Global EP Score cut off point (17/30) to identify patients at high risk of disability progression illustrated by a positive predictive value of 70%. This study provides a proof of the concept that electrophysiology could be added to MRI and used as another complementary prognostic tool in MS patients.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>27245221</pmid><doi>10.1186/s12883-016-0608-1</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2377
ispartof BMC neurology, 2016-06, Vol.16 (1), p.83-83, Article 83
issn 1471-2377
1471-2377
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4888661
source Publicly Available Content Database; PubMed Central
subjects Adult
Biological activity
Biomarkers - metabolism
Confidence intervals
Cross-Sectional Studies
Data analysis
Development and progression
Disability
Disabled Persons
Disease Progression
Electrodes
Evoked potentials
Evoked Potentials, Motor - physiology
Evoked Potentials, Somatosensory - physiology
Female
Funding
Human health sciences
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Multimodal Imaging - methods
Multiple sclerosis
Multiple Sclerosis - physiopathology
Neurologie
Neurology
NMR
Nuclear magnetic resonance
Prognosis
Retrospective Studies
ROC Curve
Sciences de la santé humaine
Variance analysis
title Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T03%3A18%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multimodal%20evoked%20potentials%20for%20functional%20quantification%20and%20prognosis%20in%20multiple%20sclerosis&rft.jtitle=BMC%20neurology&rft.au=Giffroy,%20Xavier&rft.date=2016-06-01&rft.volume=16&rft.issue=1&rft.spage=83&rft.epage=83&rft.pages=83-83&rft.artnum=83&rft.issn=1471-2377&rft.eissn=1471-2377&rft_id=info:doi/10.1186/s12883-016-0608-1&rft_dat=%3Cgale_pubme%3EA468861853%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c538t-3342a698f66f5e582b42aa8294fde9dc8ba2d83ac89dbecd3b7e31b3ba8175093%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1800718570&rft_id=info:pmid/27245221&rft_galeid=A468861853&rfr_iscdi=true